AstraZeneca PLC (OTCMKTS:AZNCF) Announces Dividend of $2.10

AstraZeneca PLC (OTCMKTS:AZNCFGet Free Report) declared a dividend on Thursday, February 6th,NASDAQ Dividends reports. Investors of record on Friday, February 21st will be paid a dividend of 2.10 per share on Monday, March 24th. The ex-dividend date is Wednesday, February 19th. This is an increase from AstraZeneca’s previous dividend of $1.00.

AstraZeneca Price Performance

Shares of OTCMKTS AZNCF opened at $151.50 on Friday. AstraZeneca has a 1-year low of $118.16 and a 1-year high of $175.00. The business’s 50 day moving average is $134.05 and its two-hundred day moving average is $146.53.

AstraZeneca Company Profile

(Get Free Report)

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.

Recommended Stories

Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca and related companies with MarketBeat.com's FREE daily email newsletter.